GRCE · Company research
Grace Therapeutics, Inc. Common Stock (GRCE): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
19records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| PRTS,AAOI,RSG,SITM,GRCE,IVZ,UBER,CURB,ATEC | Stock Prices | Quote Comparison - Yahoo! Finance Canada | PRTS,AAOI,RSG,SITM,GRCE,IVZ,UBER,CURB,ATEC | Stock Prices | Quote Comparison Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 17, 2026 | neutral | 0 | 0.6 |
| A 10% owner buys Grace Therapeutics (GRCE) shares over three days, including 36,347 on October 16. - Stock Titan | A 10% owner buys Grace Therapeutics (GRCE) shares over three days, including 36,347 on October 16. Stock Titan | View source ↗ | Stock Titan | Oct 17, 2026 | neutral | 0 | 0.6 |
| AAOI,PRTS,RSG,SITM,GRCE,IVZ,UBER,CURB,ATEC | Stock Prices | Quote Comparison - Yahoo Finance - Yahoo! Finance Canada | AAOI,PRTS,RSG,SITM,GRCE,IVZ,UBER,CURB,ATEC | Stock Prices | Quote Comparison - Yahoo Finance Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 14, 2026 | neutral | 0 | 0.6 |
| At $2.02 a share, Opaleye buys 7,215 shares of Grace Therapeutics (GRCE) - Stock Titan | At $2.02 a share, Opaleye buys 7,215 shares of Grace Therapeutics (GRCE) Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| AAOI,PRTS,RSG,SITM,GRCE,IVZ,CURB,UBER,ATEC | Stock Prices | Quote Comparison - Yahoo! Finance Canada | AAOI,PRTS,RSG,SITM,GRCE,IVZ,CURB,UBER,ATEC | Stock Prices | Quote Comparison Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 13, 2026 | neutral | 0 | 0.6 |
| PRTS,AAOI,RSG,SITM,IVZ,GRCE,CURB,UBER,ATEC | Stock Prices | Quote Comparison - Yahoo! Finance Canada | PRTS,AAOI,RSG,SITM,IVZ,GRCE,CURB,UBER,ATEC | Stock Prices | Quote Comparison Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 10, 2026 | neutral | 0 | 0.6 |
| Three purchases total 60,490 shares in Grace Therapeutics (GRCE) for Opaleye. - Stock Titan | Three purchases total 60,490 shares in Grace Therapeutics (GRCE) for Opaleye. Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| GRCE Stock On Retail Watchlist: High-Stakes FDA Decision On Brain Bleed Drug Nears - Stocktwits | GRCE Stock On Retail Watchlist: High-Stakes FDA Decision On Brain Bleed Drug Nears Stocktwits | View source ↗ | Stocktwits | Oct 5, 2026 | neutral | 0 | 0.6 |
| At $2.09 a share, Opaleye buys 7,849 shares of Grace Therapeutics (GRCE). - Stock Titan | At $2.09 a share, Opaleye buys 7,849 shares of Grace Therapeutics (GRCE). Stock Titan | View source ↗ | Stock Titan | Oct 1, 2026 | neutral | 0 | 0.6 |
| Ownership totals are corrected at Grace Therapeutics (GRCE) after purchases of 9,771 and 5,318 shares. - Stock Titan | Ownership totals are corrected at Grace Therapeutics (GRCE) after purchases of 9,771 and 5,318 shares. Stock Titan | View source ↗ | Stock Titan | Oct 1, 2026 | neutral | 0 | 0.6 |
| A fund bought 9,771 and 5,318 Grace Therapeutics (GRCE) shares in two purchases at $2.10 each. - Stock Titan | A fund bought 9,771 and 5,318 Grace Therapeutics (GRCE) shares in two purchases at $2.10 each. Stock Titan | View source ↗ | Stock Titan | Sep 23, 2026 | neutral | 0 | 0.6 |
| Grace Therapeutics (GRCE) gives director 12,200 stock options with one-year vesting - Stock Titan | Grace Therapeutics (GRCE) gives director 12,200 stock options with one-year vesting Stock Titan | View source ↗ | Stock Titan | Sep 21, 2026 | neutral | 0 | 0.6 |
| Insider Purchase: Chief Executive Officer of $GRCE Buys 100,000 Shares | GRCE Stock News - Quiver Quantitative | Insider Purchase: Chief Executive Officer of $GRCE Buys 100,000 Shares | GRCE Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 10, 2026 | neutral | 0 | 0.6 |
| GRCE Forecast — Price Target — Prediction for 2027 - TradingView | GRCE Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Grace Therapeutics: A Manufacturing Setback Priced As A Death Sentence (NASDAQ:GRCE) - Seeking Alpha | Grace Therapeutics: A Manufacturing Setback Priced As A Death Sentence (NASDAQ:GRCE) Seeking Alpha | View source ↗ | Seeking Alpha | Jun 1, 2026 | neutral | 0 | 0.6 |
| GRCE Stock Plunges 45% After FDA Rejects Brain Injury Drug — Company Says Concerns Are Fixable - Stocktwits | GRCE Stock Plunges 45% After FDA Rejects Brain Injury Drug — Company Says Concerns Are Fixable Stocktwits | View source ↗ | Stocktwits | Apr 23, 2026 | neutral | 0 | 0.6 |
| GRCE Stock Price and Chart — NASDAQ:GRCE - TradingView | GRCE Stock Price and Chart — NASDAQ:GRCE TradingView | View source ↗ | TradingView | Apr 21, 2026 | neutral | 0 | 0.6 |
| Grace Therapeutics, Inc.'s (NASDAQ:GRCE) Path To Profitability - Simply Wall Street | Grace Therapeutics, Inc.'s (NASDAQ:GRCE) Path To Profitability Simply Wall Street | View source ↗ | Simply Wall Street | Apr 13, 2026 | neutral | 0 | 0.6 |
| We're Not Very Worried About Grace Therapeutics' (NASDAQ:GRCE) Cash Burn Rate - Yahoo Finance | We're Not Very Worried About Grace Therapeutics' (NASDAQ:GRCE) Cash Burn Rate Yahoo Finance | View source ↗ | Yahoo Finance | Apr 4, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.